Inhibition of Sirt-1 Alleviates Acute and Chronic Graft-Versus-Host-Disease While Preserving Graft-Versus-Leukemia Effect

Anusara Daenthanasanmak,Supinya Iamsawat,Hung D. Nguyen,Shikhar Mehrotra,Xue-Zhong Yu
DOI: https://doi.org/10.1182/blood.v130.suppl_1.208.208
IF: 20.3
2017-01-01
Blood
Abstract:Sirtuin-1 (Sirt-1), NAD-dependent histone deacetylase, plays a crucial role in various biological processes including cellular senescence, metabolism and inflammatory responses. Sirt-1 deacetylation regulates different transcription factors that are important for modulating immune responses. An early study showed that Sirt-1 is required to maintain T cell tolerance, but more studies provided evidences that Sirt-1 promotes Th17 responses while inhibiting function of Foxp3+regulatory T cells (Tregs). Thus, the question still remains as how Sirt-1 regulates T-cell immunity versus tolerance.
What problem does this paper attempt to address?